Current and historical daily PE Ratio for Rayont Inc (
) from 2012 to May 15 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Rayont stock (RAYT) PE ratio as of May 15 2024 is 0.
More Details
Rayont Inc (RAYT) PE Ratio (TTM) Chart
Rayont Inc (RAYT) PE Ratio (TTM) Historical Data
View and export this data going back to 2012. Start your Free Trial
Total 1228
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Rayont PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-05-15 | 2.9 | 2024-03-12 | 2.9 |
| 2024-05-14 | 2.9 | 2024-03-11 | 2.9 |
| 2024-05-13 | 2.9 | 2024-03-08 | 2.9 |
| 2024-05-10 | 2.9 | 2024-03-07 | 2.9 |
| 2024-05-09 | 2.9 | 2024-03-06 | 2.9 |
| 2024-05-08 | 2.9 | 2024-03-05 | 2.9 |
| 2024-05-07 | 2.9 | 2024-03-04 | 2.9 |
| 2024-05-06 | 2.9 | 2024-03-01 | 2.9 |
| 2024-05-03 | 2.9 | 2024-02-29 | 2.9 |
| 2024-05-02 | 2.9 | 2024-02-28 | 2.9 |
| 2024-05-01 | 2.9 | 2024-02-27 | 2.9 |
| 2024-04-30 | 2.9 | 2024-02-26 | 2.9 |
| 2024-04-29 | 2.9 | 2024-02-23 | 2.9 |
| 2024-04-26 | 2.9 | 2024-02-22 | 2.9 |
| 2024-04-25 | 2.9 | 2024-02-21 | 2.9 |
| 2024-04-24 | 2.9 | 2024-02-20 | 2.9 |
| 2024-04-23 | 2.9 | 2024-02-16 | 2.9 |
| 2024-04-22 | 2.9 | 2024-02-15 | 2.9 |
| 2024-04-19 | 2.9 | 2024-02-14 | 2.9 |
| 2024-04-18 | 2.9 | 2024-02-13 | 2.9 |
| 2024-04-17 | 2.9 | 2024-02-12 | 2.9 |
| 2024-04-16 | 2.9 | 2024-02-09 | 2.9 |
| 2024-04-15 | 2.9 | 2024-02-08 | 2.9 |
| 2024-04-12 | 2.9 | 2024-02-07 | 2.9 |
| 2024-04-11 | 2.9 | 2024-02-06 | 2.9 |
| 2024-04-10 | 2.9 | 2024-02-05 | 2.9 |
| 2024-04-09 | 2.9 | 2024-02-02 | 2.9 |
| 2024-04-08 | 2.9 | 2024-02-01 | 2.9 |
| 2024-04-05 | 2.9 | 2024-01-31 | 2.9 |
| 2024-04-04 | 2.9 | 2024-01-30 | 2.9 |
| 2024-04-03 | 2.9 | 2024-01-29 | 2.9 |
| 2024-04-02 | 2.9 | 2024-01-26 | 2.9 |
| 2024-04-01 | 2.9 | 2024-01-25 | 2.9 |
| 2024-03-28 | 2.9 | 2024-01-24 | 2.9 |
| 2024-03-27 | 2.9 | 2024-01-23 | 2.9 |
| 2024-03-26 | 2.9 | 2024-01-22 | 2.9 |
| 2024-03-25 | 2.9 | 2024-01-19 | 2.9 |
| 2024-03-22 | 2.9 | 2024-01-18 | 2.9 |
| 2024-03-21 | 2.9 | 2024-01-17 | 2.9 |
| 2024-03-20 | 2.9 | 2024-01-16 | 2.9 |
| 2024-03-19 | 2.9 | 2024-01-12 | 2.9 |
| 2024-03-18 | 2.9 | 2024-01-11 | 2.9 |
| 2024-03-15 | 2.9 | 2024-01-10 | 2.9 |
| 2024-03-14 | 2.9 | 2024-01-09 | 2.9 |
| 2024-03-13 | 2.9 | 2024-01-08 | 2.9 |
Rayont Inc (RAYT) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Rayont Inc
NAICS : 311999
SIC : 8099
ISIN : US92258Y2000
Description
Rayont Inc is a clinical-stage life sciences company that holds the license for registering and commercializing Photosoft technology for the treatment of all cancers. This technology is an improved next-generation Photodynamic Therapy (PDT) that uses non-toxic photosensitizers and visible light in combination with oxygen to produce cytotoxic-reactive oxygen that kills malignant cells, shuts down tumors, and stimulates the immune system. It has been licensed in Australia, New Zealand, China, Malaysia, and Sub-Sahara Africa. It has generated revenue from digital learning solutions provided by Rayont Technologies.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers